Researchers from the School of Biomedical Engineering & Imaging Sciences conducted a systematic review on the use of MRI imaging to identify biomarkers in brain cancer. These biomarkers could potentially predict how patients respond to personalised immunotherapy treatments.
By identifying these markers before surgery, patients could receive tailored treatments earlier, potentially improving care. While immunotherapy shows promise for cancers like glioblastoma, challenges remain in developing accurate and widely applicable biomarkers. The research emphasises the need for further validated studies to overcome these challenges and refine personalised treatment approaches for brain cancer patients.